866-997-4948(US-Canada Toll Free)

Endovascular Treatment Devices: EVAR and TEVAR Emphasis

Published By :

BCC Research

Published Date : Aug 2018

Category :

Medical Equipments

No. of Pages : 124 Pages

Summary

The global market for endovascular treatment devices (EVAR and TEVAR) was worth nearly REDACTED in 2016. The market is expected to reach nearly REDACTED in 2017 and more than REDACTED by 2022, increasing at a compound annual growth rate (CAGR) of REDACTED from 2017 through 2022. This high growth is fueled by increasing acceptance of endovascular procedures (EVAR and TEVAR) and increasing diagnosis of aortic aneurysms (AAAs and TAAs) worldwide.

In 2016, the U.S. accounted for REDACTED of the global market, or REDACTED. The U.S. market should approach nearly REDACTED in 2017 and reach REDACTED by 2022, increasing at a CAGR of REDACTED from 2017 through 2022. Regionally, the U.S. is expected to maintain dominance in the global market of endovascular treatment. Those wishing to invest in the endovascular treatment devices market ought to strongly consider high-growth areas such as endovascular abdominal aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR) devices and technologies. The market is growing primarily due to the growing geriatric population, increasing prevalence of chronic diseases, continuous technological advancements, increasing adoption of endovascular techniques, and positive reimbursement and other healthcare reforms.

Report Scope

Endovascular treatment includes procedure types such as EVAR and TEVAR. Aneurysm types include infrarenal, juxtarenal and thoracic. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for endovascular treatment for aneurysms. The format of this study includes the following:
- Detailed description, including demographics and cost burden, of aortic diseases (abdominal aortic aneurysms and thoracic aortic aneurysms) and aneurysm types (e.g., infrarenal, juxtarenal and thoracic).
- Detailed description and analysis of endovascular treatment devices including EVAR and TEVAR.
- Market characterization, including unmet need, market size, and segmentation (by region and treatment).
- Market drivers and restraints.
- Detailed market projections through 2022.
- Competition and market shares.
- Key marketed and pipeline (R&D) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions regarding the future of endovascular treatment.
- Profiles of market participants and associations.

Reasons for Doing This Study

Aneurysm is a complicated and potentially deadly condition affecting millions of patients worldwide. An aortic aneurysm is a disease of the aorta in which a bulge forms in a section of the aorta, disrupting the blood supply from the heart to the rest of the body. It can lead to a stretched and weakened aorta, which may further lead to death due to bursting of the aorta. The mortality rate of a ruptured AAA is more than 80%.

Open surgical repair was introduced in the early 1950s and has become the gold standard of AAA treatment. It has long-term follow-up data and is considered as a safe and durable surgical option. However, substantial blood loss during the procedure is a widespread concern due to laparotomy and clamping of the aorta. Endovascular aneurysm repair is a relatively new procedure and offers several benefits over the traditional open procedure. It is a minimally invasive approach used to insert a stent graft (AAA or TAA stent graft) into the diseased aorta and to exclude the aneurysm bulge from circulation.

Earlier it was an alternative treatment for patients with severe comorbidities. However, now EVAR and TEVAR procedures have become the preferred treatment options for patients suffering from aneurysms. Increasing acceptance of endovascular treatment is helping patients, surgeons, payers, and providers because of improved procedure technique, faster recovery, and fewer complications. The U.S. dominates the global endovascular treatment market, followed by Europe, Asia, and the Rest of the World (ROW). The large market shares of the U.S. and Europe can be attributed to greater accessibility of advanced technologies and the presence of a large number of leading market players. The growth of the endovascular devices and technology field during the forecast period is reflective of an increasing disease incidence, rising healthcare needs, escalated healthcare spending, improvement of regional infrastructure, and growing investments by the leading players and respective government agencies.

This report is the first edition to cover the market for endovascular treatment devices and technologies used to improve aneurysm repair, with analysis of its key growth areas and quantitative market projections for technologies and devices. This study attempts to provide the reader with information about and analysis of endovascular aneurysm repair techniques and their applications in dealing with todays current challenges associated with aneurysm repair."

Report Includes

- 20 data tables and 14 additional tables
- A global overview of the endovascular treatment market with an emphasis on Endovascular Aortic Repair (EVAR) and Thoracic Endovascular Aortic/aneurysm Repair (TEVAR)
- Analyses of global market trends with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of the endovascular treatment market's regulatory structure, pricing and reimbursement, and marketed and pipelined products
- Information on endovascular surgery techniques, procedural risks and follow-up treatment, and the clinical need for endovascular procedures
- Company profiles of major players in the industry, including Boston Scientific Corp., Cardinal Health, Cook Group Inc., Getinge AB and Terumo Corp.

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Regional Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Aortic Aneurysm
Aortic Aneurysm
Causes and Risk Factors
Aging, Gender and Aortic Aneurysms
Global Demographics
U.S. Demographics
European Demographics
Japanese Demographics
Chapter 4 Abdominal Aortic Aneurysms
Disease Overview
Types of AAA
Infrarenal Aortic Aneurysms
Juxtarenal Aortic Aneurysms
Suprarenal Aortic Aneurysms
Slow-Growing AAAs
Fast-Growing AAAs
Risk Factors and Symptoms
Epidemiology and Economic Burden
Diagnosis
Treatment
Open Surgical Repair
Endovascular Aortic Repair (EVAR or EVAS)
Hybrid Approach
EVAR Versus Open Surgical Repair
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Unmet Need
Current Challenges and Future Developments
Chapter 5 Thoracic Aortic Aneurysms
Disease Overview
Types of TAA by Shape
Types of TAA by Location/Segment
Thoracoabdominal Aortic Aneurysms
Risk Factors and Symptoms
Epidemiology and Economic Burden
Diagnosis
Treatment
Open Surgical Repair
Thoracic Endovascular Aortic Repair (TEVAR)
Hybrid Approach
TEVAR Versus Open Surgical Repair
Aortic Dissection
Disease Overview
Risk Factors and Symptoms
Epidemiology
Diagnosis and Treatment
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/R&D Products
Current Challenges and Future Developments
Chapter 6 Market Size and Growth Analysis
Market Size and Growth Analysis
Market Size and Growth Analysis by Region
Market Size and Growth Analysis by Segment
Market Size and Growth Analysis by Aneurysm Location
Market Size and Growth Analysis by Aneurysm Type
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints
Chapter 7 Competitive Landscape in Endovascular Treatment Market
Competitive Landscape in Endovascular Treatment Market
Chapter 8 Market Strategies in the Endovascular Treatment Market
Recent Mergers and Acquisitions
Terumo Acquired Bolton Medical
Endologix and TriVascular Technologies Completed Merger
Cardinal Health Acquired Johnson & Johnsons Cordis Business
Lombard Medical Acquired Altura Medical
Medtronic Acquired Aptus Endosystems
Endologix Acquired Nellix
Boston Scientific Acquired TriVascular Technologies
LeMaitre Vascular Acquired Endomed
Endologix Merged with Radiance Medical
Johnson & Johnson (J&J) Through its Subsidiary Cordis Acquired TERAMed
Future Strategic Landscape
Chapter 9 Regulatory Structure: Medical Devices
Regulatory Background
Regulatory Systems for Medical Devices by Country/Region
U.S.
European Union (EU)
Japan
Chapter 10 Pricing and Reimbursement: Medical Devices
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices by Country/Region
U.S.
Europe
Japan
Chapter 11 Conclusions-Outlook for Endovascular Treatment Devices
Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Long-Term Outlook for Endovascular Treatment
Chapter 12 Company Profiles
ALTURA MEDICAL (SUBSIDIARY OF LOMBARD MEDICAL)
BIFLOW MEDICAL
BLOCKADE MEDICAL LLC (SUBSIDIARY OF BALT INTERNATIONAL)
BOLTON MEDICAL INC. (SUBSIDIARY OF VASCUTEK TERUMO)
BOSTON SCIENTIFIC CORP.
BRAILE BIOMEDICA
CARDIATIS SA
CARDINAL HEALTH
COOK GROUP INC.
CORDIS CORP. (SUBSIDIARY OF CARDINAL HEALTH INC.)
ENDOLOGIX
ENDOLUMINAL SCIENCES PTY LTD.
ENDOMED (SUBSIDIARY OF LEMAITRE VASCULAR)
ENDOSPAN
GETINGE AB
INSPIREMD
JAPAN LIFELINE CO. LTD.
KAWASUMI LABORATORIES
LEMAITRE VASCULAR INC.
LIFETECH SCIENTIFIC
LOMBARD MEDICAL TECHNOLOGIES
MEDTRONIC
MICROPORT SCIENTIFIC
MICROVENTION (SUBSIDIARY OF TERUMO)
MICRUS ENDOVASCULAR (SUBSIDIARY OF JOHNSON & JOHNSON)
NELLIX INC. (SUBSIDIARY OF ENDOLOGIX)
PENUMBRA
TERUMO CORP.
TRANSCATHETER TECHNOLOGIES
TRIVASCULAR TECHNOLOGIES (SUBSIDIARY OF ENDOLOGIX INC.)
W.L. GORE AND ASSOCIATES
Chapter 13 Appendix A: Acronyms
Chapter 14 Appendix B: Professional Organizations
American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare & Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)

List of Table

List of Tables
Summary Table : Global Market for Endovascular Treatment Devices, by Region, Through 2022
Table 1 : Epidemiology, TAA vs. AAA
Table 2 : Leading Peripheral Vascular Disease Conditions, by Type
Table 3 : Global Prevalence of Peripheral Artery Disease, Through 2020
Table 4 : Global Incidence Shares of Hypertension, by Patient Group, 2016
Table 5 : BMI Calculation
Table 6 : BMI Categories Based on Increasing Health Risks
Table 7 : Trends in Obesity Composition of the World's Population, Through 2021
Table 8 : U.S. Obese and Severely Obese vs. General Population, Through 2021
Table 9 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 10 : World Population, by Region, Through 2030
Table 11 : U.S. Population Estimates and Projections, by Age Group, Through 2030
Table 12 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
Table 13 : European Population Estimates and Projections, by Age Group, Through 2030
Table 14 : Japanese Population Estimates and Projections, by Age Group, Through 2030
Table 15 : Prevalence of AAA, Global vs. U.S., Through 2022
Table 16 : Imaging Techniques for AAA Diagnosis
Table 17 : Size of AAA, Estimated Annual Risk of Rupture
Table 18 : Key Marketed Products, Endovascular Systems for AAA
Table 19 : Key Pipeline/R&D Products, Endovascular Systems for AAA
Table 20 : Prevalence of TAA, Global vs. U.S., Through 2022
Table 21 : Key Marketed Products, Endovascular Systems for TAA
Table 22 : Key Pipeline/R&D Products, Endovascular Systems for TAA
Table 23 : Global Market for Endovascular Treatment Devices, by Region, Through 2022
Table 24 : Global Market for Endovascular Treatment Devices, by Segment, Through 2022
Table 25 : Global Market for Aneurysm Repair (EVAR and Open Surgical Repair), by Aneurysm Type, Through 2022
Table 26 : Global Market for Endovascular Treatment Devices, by Leading Company, 2016
Table 27 : Recent Key Strategic Deals in Endovascular Treatment Market
Table 28 : Differences in Regulatory Approval in the U.S. and Europe
Table 29 : Endovascular Procedures, Billing and Reimbursement, U.S.
Table 30 : Operations on Abdominal Aorta, ICD-10 Procedure Codes
Table 31 : Hospital Inpatient Procedures Utilizing MS-DRGs, National Average Reimbursement, CMS
Table 32 : Trends in Per Capita Real GDP Growth, by Region, 2012-2016
Table 33 : List of Acronyms

List of Chart

List of Figures
Summary Figure : Global Market for Endovascular Treatment Devices, by Region, 2016-2022
Figure 1 : Global Prevalence of Peripheral Artery Disease, 2000-2020
Figure 2 : Global Incidence Shares of Hypertension, by Patient Group, 2016
Figure 3 : Trends in Obesity Composition of the World's Population, 2012-2021
Figure 4 : U.S. Obese and Severely Obese vs. General Population, 2016 and 2021
Figure 5 : Estimated World Population and Annual Growth, by Selected Age Group, 2000-2030
Figure 6 : World Population, by Region, 2000-2030
Figure 7 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
Figure 8 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
Figure 9 : European Population Estimates and Projections, by Age Group, 2000-2030
Figure 10 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
Figure 11 : Prevalence of AAA, Global vs. U.S., 2016-2022
Figure 12 : Prevalence of TAA, Global vs. U.S., 2016-2022
Figure 13 : Global Market for Endovascular Treatment Devices, by Region, 2016-2022
Figure 14 : Global Market for Endovascular Treatment Devices, by Segment, 2016-2022
Figure 15 : Global Market Shares for EVAR and TEVAR, by Aneurysm Location, 2017
Figure 16 : Global Market Shares for EVAR and TEVAR, by Aneurysm Complexity, 2017
Figure 17 : Global Market for Aneurysm Repair (EVAR and Open Surgical Repair), by Aneurysm Type, 2016-2022
Figure 18 : Global Market Shares for Aortic Repair Procedures, by Surgery Type, 2017
Figure 19 : Global Market Shares for Endovascular Treatment Devices, by Leading Company, 2016
Figure 20 : Trends in Per Capita Real GDP Growth, by Region, 2012-2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *